The Enterprise Value as of June 2026 (TTM) for Channel Therapeutics Corporation (CHRO) is 2.86M

According to Channel Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 2.86M. This represents a change of -97.98% compared to the average of 141.65M of the last 4 quarters.

Channel Therapeutics Corporation (CHRO) Historical Enterprise Value (quarterly & annually)

How has CHRO Enterprise Value performed in the past?

The mean historical Enterprise Value of Channel Therapeutics Corporation over the last ten years is 263.39M. The current 2.86M Enterprise Value has changed 8.71% with respect to the historical average. Over the past ten years (40 quarters), CHRO's Enterprise Value was at its highest in in the December 2025 quarter at 432.56M. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.

Channel Therapeutics Corporation (CHRO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Channel Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Channel Therapeutics Corporation (CHRO) Average Enterprise Value

How has CHRO Enterprise Value performed in the past?

The current Enterprise Value of Channel Therapeutics Corporation (CHRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Channel Therapeutics Corporation (CHRO) Enterprise Value vs. Peers

How is CHRO’s Enterprise Value compared to its peers?

Channel Therapeutics Corporation’s Enterprise Value is less than Tvardi Therapeutics, Inc. (5.09M), less than TNF Pharmaceuticals, Inc. (5.71M), less than Omega Therapeutics, Inc. (67.88M), greater than Turnstone Biologics Corp. (-8062051.00), less than IMV Inc. (17.06M), less than CervoMed Inc. (14.74M), greater than Apexigen, Inc. (-5121682.00), greater than COSCIENS Biopharma Inc. (-24112361.33), less than Biora Therapeutics, Inc. (32.22M), less than ObsEva S.A. (5.60M),

Build a custom stock screener for Channel Therapeutics Corporation (CHRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Channel Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Channel Therapeutics Corporation (CHRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Channel Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.